New Clinical Trial To Test Effectiveness Of Vorinostat (Zolinza) On Malignant Pleural Mesothelioma
New Clinical Trial To Test Effectiveness Of Vorinostat (Zolinza) On Malignant Pleural Mesothelioma
|
A phase III clinical trial is underway, in Maryland, at the National Institutes of Health Clinical Center, to determine how effective vorinostat is at treating patients with pleural malignant mesothelioma . Research is underway specifically about Vorinostat, also known as suberoylanilide hydroxamic acid, is marketed under the brand name Zolinza. [click link for full article] |
read more...
News entry number 1039 added on Sep 7, 2007 in the Health category.
Comenteaza
Other News in the Health category
Categorie:
Categorie:
Categorie:
Categorie:
Categorie:
Related Links
- New York Methodist Hospital Set To Begin A Clinical Trial That May Help Emphysema Sufferers Breathe
- FDA Licenses 15 New Blood Typing Tests - Tests Help Ensure Safe Blood Transfusions For Patients
- Multiple flu vaccine shows promise in clinical trials, say its makers
- Former Enron Chief Seeks New Trial
- Urodynamix Commences Enrollment In Third IAP Clinical Trial
- Newspapers Report Medicaid Developments In Maryland, New York, Wisconsin
- New Schizophrenia Drug Shows Promise In Phase II Human Trials
- New Quick And Cheap Bird Flu Test
- Malaysia is the latest to test Qualcomm's MediaFlo
News Categories
745
522
479
347
1003
691
279
973
Top 10 News
- Texas Woman Claims to Have Found Mythical 'Chupacabra'
- Wireless technology hits security budgets
- Google Starts Hosting News on Website
- Study Focuses On Cancer Risk In Biologic Treatment For Rheumatoid Arthritis
- Google forced to push image in China
- Ho-hum, the guest's another candidate
- Microsoft purchase of RIM nice to consider, but unlikely
- Western School Board limits digital devices
- 'Spooky' science points to quantum internet
- Nuñez, gov. gamble on healthcare overhaul
Statistics
News:
News Categories:
News Read:
News Categories:
News Read:
5039
8
621
8
621